|Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia|
S Akhondzadeh, F Rezaei, B Larijani, AA Nejatisafa, L Kashani, ...
Schizophrenia research 84 (2-3), 405-410, 2006
|N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study|
M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ...
Clinical neuropharmacology 36 (6), 185-192, 2013
|Intranasal oxytocin as an adjunct to risperidone in patients with schizophrenia|
A Modabbernia, F Rezaei, B Salehi, M Jafarinia, M Ashrafi, M Tabrizi, ...
CNS drugs 27 (1), 57-65, 2013
|Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania|
Z Amrollahi, F Rezaei, B Salehi, AH Modabbernia, A Maroufi, ...
Journal of affective disorders 129 (1-3), 327-331, 2011
|Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study|
MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ...
Psychiatry Research 215 (3), 540-546, 2014
|The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial|
SH Abbasi, H Behpournia, A Ghoreshi, B Salehi, M Raznahan, ...
Schizophrenia research 116 (2-3), 101-106, 2010
|Efficient or opportunistic earnings management with regards to the role of firm size and corporate governance practices|
F Rezaei, M ROSHAN
INTERDISCIPLINARY JOURNAL OF CONTEMPORARY RESEARCH IN BUSINESS 3 (9), 1312-1322, 2012
|Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study|
F Rezaei, M Mohammad-Karimi, S Seddighi, A Modabbernia, M Ashrafi, ...
Journal of clinical psychopharmacology 33 (3), 336-342, 2013
|Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial|
S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ...
Bipolar disorders 17 (6), 606-614, 2015
|Sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled trial|
S Akhondzadeh, R Ghayyoumi, F Rezaei, B Salehi, AH Modabbernia, ...
Psychopharmacology 213 (4), 809-815, 2011
|A double-blind placebo controlled trial of Ginkgo biloba added to risperidone in patients with autistic disorders|
E Hasanzadeh, MR Mohammadi, A Ghanizadeh, SA Rezazadeh, ...
Child Psychiatry & Human Development 43 (5), 674-682, 2012
|Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial|
G Kianimehr, F Fatehi, S Hashempoor, MR Khodaei-Ardakani, F Rezaei, ...
DARU Journal of Pharmaceutical Sciences 22 (1), 1-7, 2014
|Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double‐blind comparison trial|
AR Zarinara, MR Mohammadi, N Hazrati, M Tabrizi, SA Rezazadeh, ...
Human Psychopharmacology: Clinical and Experimental 25 (7‐8), 530-535, 2010
|A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia|
M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ...
Psychopharmacology 228 (4), 595-602, 2013
|Comparison of self-esteem, locus of control and their relationship with university students’ educational status at Shahid Sadoughi University of Medical Sciences-Yazd|
M Mirzaei Alavijeh, N Rajaei, F Rezaei, S Hasanpoor, R Pirouzeh, ...
The Journal of Medical Education and Development 7 (1), 58-70, 2012
|A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia|
M Farokhnia, M Sabzabadi, H Pourmahmoud, MR Khodaie-Ardakani, ...
Psychopharmacology 231 (3), 533-542, 2014
|Sustained-release methylphenidate in methamphetamine dependence treatment: a double-blind and placebo-controlled trial|
F Rezaei, M Emami, S Zahed, MJ Morabbi, M Farahzadi, S Akhondzadeh
DARU Journal of Pharmaceutical Sciences 23 (1), 1-8, 2015
|A SURVEY OF SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES STUDENTS'OPINIONS ABOUT RESEARCH BARRIERS DURING UNIVERSITY TRAINING|
MSS MAZLOOMY, SP Hosseini, SM ABBASI, AM MIRZAEI, F Rezaei
JOURNAL OF MEDICAL EDUCATION DEVELOPMENT 6 (10), 63-70, 2013
|Topiramate for the management of methamphetamine dependence: a pilot randomized, double‐blind, placebo‐controlled trial|
F Rezaei, E Ghaderi, R Mardani, S Hamidi, K Hassanzadeh
Fundamental & clinical pharmacology 30 (3), 282-289, 2016
|L-lysine as an adjunct to risperidone in patients with chronic schizophrenia: a double-blind, placebo-controlled, randomized trial|
A Zeinoddini, M Ahadi, M Farokhnia, F Rezaei, M Tabrizi, S Akhondzadeh
Journal of psychiatric research 59, 125-131, 2014